%D8%B6%D8%AF_%D9%88%D8%AD%D9%8A%D8%AF_%D8%A7%D9%84%D9%86%D8%B3%D9%8A%D9%84%D8%A9Monoklonska_%D0%B0ntitijelaAntic%C3%B2s_monoclonalMonoklon%C3%A1ln%C3%AD_protil%C3%A1tkaMonoklonaler_Antik%C3%B6rperMonoclonal_antibodyAnticuerpo_monoclonalAntigorputz_monoklonal%D9%BE%D8%A7%D8%AF%D8%AA%D9%86_%D9%85%D9%88%D9%86%D9%88%DA%A9%D9%84%D9%88%D9%86%D8%A7%D9%84Monoklonaalinen_vasta-aineAnticorps_monoclonalAntashubstaint_mhonacl%C3%B3nachAnticorpo_monoclonal%D7%A0%D7%95%D7%92%D7%93%D7%A0%D7%99%D7%9D_%D7%97%D7%93-%D7%A9%D7%91%D7%98%D7%99%D7%99%D7%9DAntibodi_monoklonalAnticorpo_monoclonale%E3%83%A2%E3%83%8E%E3%82%AF%E3%83%AD%E3%83%BC%E3%83%8A%E3%83%AB%E6%8A%97%E4%BD%93%D0%9C%D0%BE%D0%BD%D0%BE%D0%BA%D0%BB%D0%BE%D0%BD%D0%B0%D0%BB%D1%8C%D0%B4%D1%8B_%D0%B0%D0%BD%D1%82%D0%B8%D0%B4%D0%B5%D0%BD%D0%B5%D0%BB%D0%B5%D1%80%EB%8B%A8%ED%81%B4%EB%A1%A0%ED%95%AD%EC%B2%B4Antibodi_monoklonMonoklonale_antistofMonoklonale_antistofferPrzeciwcia%C5%82a_monoklonalneAnticorpo_monoclonalAnticorp_monoclonal%D0%9C%D0%BE%D0%BD%D0%BE%D0%BA%D0%BB%D0%BE%D0%BD%D0%B0%D0%BB%D1%8C%D0%BD%D1%8B%D0%B5_%D0%B0%D0%BD%D1%82%D0%B8%D1%82%D0%B5%D0%BB%D0%B0Monoklonalno_antiteloMonoklonska_protitelesaMonoklonalno_antiteloMonoklonal_antikropp%E0%AE%93%E0%AE%B0%E0%AE%BF%E0%AE%A9_%E0%AE%8E%E0%AE%A4%E0%AE%BF%E0%AE%B0%E0%AF%8D%E0%AE%AA%E0%AF%8D%E0%AE%AA%E0%AE%BE%E0%AE%A9%E0%AF%8D%E0%AE%95%E0%AE%B3%E0%AF%8D%E0%B8%AA%E0%B8%B2%E0%B8%A3%E0%B8%A0%E0%B8%B9%E0%B8%A1%E0%B8%B4%E0%B8%95%E0%B9%89%E0%B8%B2%E0%B8%99%E0%B8%97%E0%B8%B2%E0%B8%99%E0%B9%82%E0%B8%A1%E0%B9%82%E0%B8%99%E0%B9%82%E0%B8%84%E0%B8%A5%E0%B8%99Monoklonal_antikor%D0%9C%D0%BE%D0%BD%D0%BE%D0%BA%D0%BB%D0%BE%D0%BD%D0%B0%D0%BB%D1%8C%D0%BD%D1%96_%D0%B0%D0%BD%D1%82%D0%B8%D1%82%D1%96%D0%BB%D0%B0Anticoirs_monoclon%C3%A5sQ422248%E5%96%AE%E6%A0%AA%E6%8A%97%E9%AB%94%E5%8D%95%E5%85%8B%E9%9A%86%E6%8A%97%E4%BD%93
about
sameAs
P1056
EldelumabLexatumumabEnsituximabInclacumabIxekizumabpembrolizumabEvolocumabOtlertuzumabAducanumabbimagrumabOntuxizumabAnifrolumabGuselkumabTildrakizumabTechnetium (99mTc) votumumabVadastuximab talirinezolbetuximabPankomablilotomabIdarucizumabMDX-1097BesilesomabBococizumababrilumabAscrinvacumabDiridavumabDurvalumabEmibetuzumabEnfortumab vedotinEnoblituzumabEvinacumabFletikumabSeribantumabPolatuzumab vedotinPinatuzumab vedotinBelimumabPertuzumabOcrelizumablulizumab pegolObiltoxaximab
P31
A safety review and meta-analyses of bevacizumab and ranibizumab: off-label versus goldstandardInterleukin-6: a new therapeutic targetAssociation of cetuximab with adverse pulmonary events in cancer patients: a comprehensive reviewProfile of certolizumab and its potential in the treatment of psoriatic arthritisPossible future monoclonal antibody (mAb)-based therapy against arbovirus infectionsMonoclonal antibodies targeting cancer: 'magic bullets' or just the trigger?Ustekinumab in psoriasis immunopathology with emphasis on the Th17-IL23 axis: a primerThe role of RANK-ligand inhibition in cancer: the story of denosumabNimotuzumab, a promising therapeutic monoclonal for treatment of tumors of epithelial originUpdate on HER-2 as a target for cancer therapy: herceptin in the clinical setting.Therapy of ankylosing spondylitis and other spondyloarthritides: established medical treatment, anti-TNF-alpha therapy and other novel approachesGolimumab in radiographic and nonradiographic axial spondyloarthritis: a review of clinical trialsSecukinumab for rheumatology: development and its potential place in therapyA Mini-Review for Cancer Immunotherapy: Molecular Understanding of PD-1/PD-L1 Pathway & Translational Blockade of Immune CheckpointsEmerging Technologies and Generic Assays for the Detection of Anti-Drug Antibodies.Elotuzumab for the treatment of multiple myelomaAn appraisal of golimumab in the treatment of severe, active nonradiographic axial spondyloarthritisA review of omalizumab for the management of severe asthmaDaratumumab: a first-in-class CD38 monoclonal antibody for the treatment of multiple myelomaPCSK9 inhibition in the management of hyperlipidemia: focus on evolocumabPosttranslational Modifications and the Immunogenicity of BiotherapeuticsTherapeutic options in peripheral T cell lymphomaPemetrexed Maintenance Therapy Following Bevacizumab-Containing First-Line Chemotherapy in Advanced Malignant Pleural Mesothelioma: A Case Report and Literatures ReviewMethotrexate monotherapy and methotrexate combination therapy with traditional and biologic disease modifying antirheumatic drugs for rheumatoid arthritis: abridged Cochrane systematic review and network meta-analysisDNA immunization as a technology platform for monoclonal antibody inductionCancer immunotherapy: the beginning of the end of cancer?Linkers Having a Crucial Role in Antibody-Drug ConjugatesClinical efficacy and safety of evolocumab for low-density lipoprotein cholesterol reductionRituximab Effectiveness and Safety for Treating Primary Sjögren's Syndrome (pSS): Systematic Review and Meta-AnalysisReversing anticoagulant effects of novel oral anticoagulants: role of ciraparantag, andexanet alfa, and idarucizumabAdvances in recombinant antibody manufacturingInvolvement of HMGB1 in Resistance to Tumor Vessel-Targeted, Monoclonal Antibody-Based ImmunotherapyThe Efficacy and Safety of Antiinterleukin 13, a Monoclonal Antibody, in Adult Patients With Asthma: A Systematic Review and Meta-AnalysisThe changing landscape of biosimilars in rheumatologyMonoclonal antibodies targeting CD38 in hematological malignancies and beyondAssociation between Genetic Polymorphisms and Response to Anti-TNFs in Patients with Inflammatory Bowel DiseaseImmunotherapy in Chronic Lymphocytic Leukaemia (CLL)Advances in immunotherapy for melanomaPD-1/PD-L1 blockade in cancer treatment: perspectives and issuesMethods to Design and Synthesize Antibody-Drug Conjugates (ADCs)
P921
description
monospecific antibody that is ...... clones of a unique parent cell
@en
name
Antashubstaint mhonaclónach
@ga
Antibodi monoklon
@ms
Antibodi monoklonal
@id
Anticoirs monoclonås
@wa
Anticorp monoclonal
@ro
Anticorpo monoclonal
@gl
Antigorputz monoklonal
@eu
Monoklonaalinen vasta-aine
@fi
Monoklonal antikor
@tr
Monoklonal antikropp
@sv
type
label
Antashubstaint mhonaclónach
@ga
Antibodi monoklon
@ms
Antibodi monoklonal
@id
Anticoirs monoclonås
@wa
Anticorp monoclonal
@ro
Anticorpo monoclonal
@gl
Antigorputz monoklonal
@eu
Monoklonaalinen vasta-aine
@fi
Monoklonal antikor
@tr
Monoklonal antikropp
@sv
altLabel
-mab
@nn
Antibodies, Monoclonal
@en
Anticoir monoclonå
@wa
Anticorpi monoclonali
@it
Anticorpos monoclonais
@pt
Anticorps Monoclonaux
@fr
Anticuerpos monoclonales
@es
MAb
@es
MoAb
@cs
Monoclonal Antibody
@en
prefLabel
Antashubstaint mhonaclónach
@ga
Antibodi monoklon
@ms
Antibodi monoklonal
@id
Anticoirs monoclonås
@wa
Anticorp monoclonal
@ro
Anticorpo monoclonal
@gl
Antigorputz monoklonal
@eu
Monoklonaalinen vasta-aine
@fi
Monoklonal antikor
@tr
Monoklonal antikropp
@sv
P672
P244
P486
P508
P6366
P646
P1296
P1417
science/monoclonal-antibody
P244
sh85005650
P2868
P3219
anticorps-monoclonaux
P3471
P3569
levenswetenschappen-en-geneeskunde/monoklonale-antistoffen
P373
Monoclonal antibodies
P3827
monoclonal-antibodies
P4732
P486
P6366
P646
P672
D12.776.124.486.485.114.224
D12.776.124.790.651.114.224
D12.776.377.715.548.114.224